References and Notes
<A NAME="RG27309ST-1A">1a</A>
Littke A. In Modern
Arylation Methods
Ackermann L.
Wiley-VCH;
Weinheim:
2009.
p.25
<A NAME="RG27309ST-1B">1b</A>
Catellani M.
Motti E.
Della Ca’ N.
Ferraccioli R.
Eur.
J. Org. Chem.
2007,
4153
<A NAME="RG27309ST-1C">1c</A>
Alberico D.
Scott ME.
Lautens M.
Chem.
Rev.
2007,
107:
174
<A NAME="RG27309ST-1D">1d</A>
Suzuki A. In Boronic Acids. Preparation, Applications in
Organic Synthesis and Medicine
Hall DG.
Wiley-VCH;
Weinheim:
2005.
p.123
For recent selected reviews, see:
<A NAME="RG27309ST-2A">2a</A>
Alonso F.
Beletskaya IP.
Yus M.
Tetrahedron
2008,
64:
3047
<A NAME="RG27309ST-2B">2b</A>
Miyaura N. In Metal-Catalyzed Cross-Coupling Reactions
2nd
ed., Vol. 1:
de Meijere A.
Diederich F.
Wiley-VCH;
Weinheim:
2004.
p.41
For recent reviews, see:
<A NAME="RG27309ST-3A">3a</A>
Martin R.
Buchwald SL.
Acc. Chem. Res.
2008,
41:
1461
<A NAME="RG27309ST-3B">3b</A>
Fu GC.
Acc.
Chem. Res.
2008,
41:
1555
For representative examples, see:
<A NAME="RG27309ST-4A">4a</A>
Littke AF.
Dai C.
Fu GC.
J. Am. Chem. Soc.
2000,
122:
4020
<A NAME="RG27309ST-4B">4b</A>
Zapf A.
Ehrentraut A.
Beller M.
Angew.
Chem. Int. Ed.
2000,
39:
4153
<A NAME="RG27309ST-4C">4c</A>
Walker SD.
Barder TE.
Martinelli JR.
Buchwald SL.
Angew.
Chem. Int. Ed.
2004,
43:
1871
For recent reviews, see:
<A NAME="RG27309ST-5A">5a</A>
Marion N.
Nolan SP.
Acc. Chem. Res.
2008,
41:
1440
<A NAME="RG27309ST-5B">5b</A>
Würtz S.
Glorius F.
Acc. Chem.
Res.
2008,
41:
1523
<A NAME="RG27309ST-5C">5c</A>
Organ MG.
Chass GA.
Fang D.-C.
Hopkinson AC.
Valente C.
Synthesis
2008,
2776
<A NAME="RG27309ST-5D">5d</A>
Kantchev EAB.
O’Brien CJ.
Organ MG.
Angew. Chem. Int. Ed.
2007,
46:
2768
For representative examples, see:
<A NAME="RG27309ST-6A">6a</A>
Gstöttmayr CWK.
Böhm VPW.
Herdtweck E.
Grosche M.
Herrmann
WA.
Angew.
Chem. Int. Ed.
2002,
41:
1363
<A NAME="RG27309ST-6B">6b</A>
Herrmann WA.
Öfele K.
Schneider SK.
Herdtweck E.
Hoffmann SD.
Angew. Chem. Int. Ed.
2006,
45:
3859
<A NAME="RG27309ST-6C">6c</A>
Diebolt O.
Braunstein P.
Nolan SP.
Cazin CSJ.
Chem. Commun.
2008,
3190
<A NAME="RG27309ST-6D">6d</A>
Organ MG.
Çalimsiz S.
Sayah M.
Hoi KH.
Lough AJ.
Angew. Chem. Int. Ed.
2009,
48:
2383
<A NAME="RG27309ST-7">7</A>
Palladacycles: Synthesis,
Characterization and Applications
Dupont J.
Pfeffer M.
Wiley-VCH;
Weinheim:
2008.
<A NAME="RG27309ST-8A">8a</A>
Bedford RB.
Cazin CSJ.
Chem. Commun.
2001,
1540
<A NAME="RG27309ST-8B">8b</A>
Schnyder A.
Indolese AF.
Studer M.
Blaser H.-U.
Angew. Chem. Int. Ed.
2002,
41:
3668
<A NAME="RG27309ST-8C">8c</A>
Bedford RB.
Cazin CSJ.
Hazelwood SL.
Angew. Chem. Int. Ed.
2002,
41:
4120
<A NAME="RG27309ST-9">9</A>
Navarro O.
Kelly RA.
Nolan SP.
J.
Am. Chem. Soc.
2003,
125:
16194
<A NAME="RG27309ST-10">10</A>
Alacid E.
Alonso DA.
Botella L.
Nájera C.
Pacheco MC.
Chem. Rec.
2006,
6:
117
<A NAME="RG27309ST-11A">11a</A>
Alonso DA.
Nájera C.
Pacheco MC.
Org.
Lett.
2000,
2:
1823
<A NAME="RG27309ST-11B">11b</A>
Alonso DA.
Nájera C.
Pacheco MC.
J. Org. Chem.
2002,
67:
5588
<A NAME="RG27309ST-12A">12a</A>
Botella L.
Nájera C.
Angew.
Chem. Int. Ed.
2002,
41:
179
<A NAME="RG27309ST-12B">12b</A>
Botella L.
Nájera C.
J. Organomet. Chem.
2002,
663:
46
<A NAME="RG27309ST-12C">12c</A>
Alacid E.
Nájera C.
J. Organomet. Chem.
2009,
694:
1658
<A NAME="RG27309ST-13">13</A>
Appukkuttan P.
Van der Eyken E.
Eur.
J. Org. Chem.
2008,
1133
<A NAME="RG27309ST-14">14</A>
Netherton MR.
Fu GC.
Org. Lett.
2001,
3:
4295
<A NAME="RG27309ST-15">15</A>
At this point, the efficiency of the
previously tested phosphane ligands with TBAOH as additive was tested again,
showing in all cases lower activities. For example, P(t-Bu)3 only led to a 31% isolated
yield of 4a.
<A NAME="RG27309ST-16">16</A>
Goubet D.
Meric P.
Dormoy J.-R.
Moreau P.
J. Org. Chem.
1999,
64:
4516
<A NAME="RG27309ST-17">17</A>
Typical Procedure
for the Suzuki Coupling under MW Irradiation Conditions (Table 2,
Entry 3)
A freshly stock soln of catalyst 1 (150 µg, 0.019 mmol) in DMF
(2.5 mL) and [HP(t-Bu)3]BF4 (110
g, 0.0375 mmol) in DMF (2.5 mL) were previously prepared and used.
A 10 mL MW vessel was charged with K2CO3 (1.5
mmol, 207 mg), TBAOH (0.15 mmol, 120 mg), PhB(OH)2 (1.88
mmol, 225 mg), catalyst 1 (250 µL
of the stock soln, 0.0019 mmol, 15 µg, 0.5 mol% Pd), [HP(t-Bu)3]BF4 (250 µL
of the stock soln, 0.00375 mmol, 11 µg), 4-chloroanisole
(0.75 mmol, 92 µL), and DMF (1.5 mL). The vessel was sealed
with a pressure lock, and the mixture was heated in air at 130 ˚C
by a MW irradiation of 40 W for 20 min in a CEM Discover MW reactor.
After allowing the reaction to cool down to r.t., the mixture was
filtered through a pad of Celite and poured into an excess of H2O
(5 mL) and extracted with Et2O (3 × 5
mL). The combined organic phases were washed with H2O
(3 × 5 mL), dried (MgSO4),
and evaporated. The obtained crude product was purified by recrystallization
in MeOH-H2O (3:1), yielding 102 mg of pure 4-methoxybiphenyl
(4a, 74%) as a white solid; mp
89-93 ˚C. ¹H NMR (300 MHz,
CDCl3): δ = 7.57-7.51 (m,
4 H, ArH), 7.42 (t, J = 7.5
Hz, 2 H, ArH), 7.30 (t, J = 7.2
Hz, 1 H, ArH), 6.98 (d, J = 8.7
Hz, 2 H, ArH), 3.86 (s, 3 H, CHO). MS (EI, 70 eV): m/z (%) = 184
(100) [M+], 169 (49) [M+ - Me],
141 (49), 139 (13), 115 (35).
<A NAME="RG27309ST-18A">18a</A>
p-Biphenylacetic acid(felbinac) and 2-ethyl-4-biphenylacetic
acid with dimethylaminoethanol-(namoxyrate) are anti-inflamatory
and analgesic drugs, respectively: USP Dictionary of USAN and International Drugs
names.
<A NAME="RG27309ST-18B">18b</A>
p-Biphenylacetamides
have been used as mesogenic arms in porphyrin thermotropic liquid
crystals:
Michaeli S.
Hugerat M.
Levanon H.
Bernitz M.
Natt A.
Neumann R.
J.
Am. Chem. Soc.
1992,
114:
3612